Psoriasis Drug May Have Some Cardiometabolic Benefits
Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.
Source: medscape.com
Stay updated with breaking news from Reductions Maintained. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nonrandomized trial shows 5%-6% reduction in both visceral and subcutaneous fat, but no effect on aortic vascular inflammation.